AAPL295.18+5.82 (+2.01%) ▲|ABBV249.56-2.08 (-0.83%) ▼|ABT92.85+2.11 (+2.33%) ▲|ACN131.13+6.69 (+5.38%) ▲|ADBE212.61+7.59 (+3.70%) ▲|AMAT663.31-59.69 (-8.26%) ▼|AMD551.15-29.77 (-5.12%) ▼|AMGN360.80-1.32 (-0.36%) ▼|AMT165.55+1.98 (+1.21%) ▲|AMZN241.81+3.47 (+1.46%) ▲|AVGO370.59-7.16 (-1.90%) ▼|AXP348.72+10.47 (+3.10%) ▲|BA217.87+1.40 (+0.65%) ▲|BAC58.23+1.25 (+2.19%) ▲|BKNG184.71+6.47 (+3.63%) ▲|BLK978.17+16.61 (+1.73%) ▲|BMY56.66-0.97 (-1.67%) ▼|BNY146.74+2.13 (+1.47%) ▲|BRK-B503.15+2.76 (+0.55%) ▲|C140.73+0.77 (+0.55%) ▲|CAT1,019.34-45.56 (-4.28%) ▼|CL92.49+0.81 (+0.88%) ▲|CMCSA24.16-0.39 (-1.59%) ▼|COF204.94+4.32 (+2.15%) ▲|COP103.74-0.22 (-0.21%) ▼|COST926.70-8.77 (-0.94%) ▼|CRM164.94+8.28 (+5.28%) ▲|CSCO116.33-1.13 (-0.96%) ▼|CVS104.11+0.66 (+0.63%) ▲|CVX166.32+0.56 (+0.34%) ▲|DE631.49-2.84 (-0.45%) ▼|DHR194.76+4.28 (+2.24%) ▲|DIS97.04+0.79 (+0.82%) ▲|DUK126.18-0.40 (-0.32%) ▼|EMR142.47-0.68 (-0.48%) ▼|FDX315.03+1.90 (+0.61%) ▲|GD364.11+9.87 (+2.79%) ▲|GE375.80+2.07 (+0.55%) ▲|GEV1,153.80-21.06 (-1.79%) ▼|GILD126.20-0.15 (-0.11%) ▼|GM76.53-0.56 (-0.72%) ▼|GOOG356.33+3.00 (+0.85%) ▲|GOOGL359.45+2.08 (+0.58%) ▲|GS1,024.23+12.86 (+1.27%) ▲|HD356.34+3.66 (+1.04%) ▲|HON224.19+0.29 (+0.13%) ▲|IBM293.10+11.89 (+4.23%) ▲|INTC129.30-10.33 (-7.40%) ▼|INTU272.00+11.00 (+4.21%) ▲|ISRG404.99+7.31 (+1.84%) ▲|JNJ252.34-1.63 (-0.64%) ▼|JPM334.34+7.01 (+2.14%) ▲|KO81.76+0.49 (+0.60%) ▲|LIN536.04+17.10 (+3.30%) ▲|LLY1,191.20-8.24 (-0.69%) ▼|LMT521.48+12.02 (+2.36%) ▲|LOW225.28+4.79 (+2.17%) ▲|LRCX396.34-36.99 (-8.54%) ▼|MA528.55+14.95 (+2.91%) ▲|MCD270.44+0.13 (+0.05%) ▲|MDLZ59.17+1.33 (+2.29%) ▲|MDT79.40+1.17 (+1.50%) ▲|META618.43+55.14 (+9.79%) ▲|MMM161.68-0.23 (-0.14%) ▼|MO71.96+0.01 (+0.01%) ▲|MRK126.59-1.91 (-1.49%) ▼|MS211.51+2.47 (+1.18%) ▲|MSFT384.67+11.65 (+3.12%) ▲|MU1,053.73-100.57 (-8.71%) ▼|NEE86.95-0.82 (-0.93%) ▼|NFLX73.39+1.99 (+2.78%) ▲|NKE43.06+2.01 (+4.90%) ▲|NOW105.65+6.37 (+6.42%) ▲|NVDA196.89-3.20 (-1.60%) ▼|ORCL145.11-1.44 (-0.98%) ▼|PEP140.05+4.65 (+3.43%) ▲|PFE23.94-0.15 (-0.60%) ▼|PG146.37-0.27 (-0.18%) ▼|PLTR127.19+10.52 (+9.02%) ▲|PM178.43-2.48 (-1.37%) ▼|QCOM185.52+0.73 (+0.39%) ▲|RTX191.39+1.66 (+0.87%) ▲|SBUX101.57-0.63 (-0.61%) ▼|SCHW94.40+2.13 (+2.31%) ▲|SO95.79+0.08 (+0.08%) ▲|SPG221.82-1.84 (-0.82%) ▼|T20.64-0.06 (-0.29%) ▼|TMO520.60+19.24 (+3.84%) ▲|TMUS172.53+4.80 (+2.86%) ▲|TSLA429.34+8.74 (+2.08%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.35+1.19 (+1.65%) ▲|UNH421.65+6.02 (+1.45%) ▲|UNP276.15+4.15 (+1.53%) ▲|UPS109.83+2.33 (+2.17%) ▲|USB61.98+1.58 (+2.62%) ▲|V352.39+9.30 (+2.71%) ▲|VZ42.08-0.27 (-0.63%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.05-5.21 (-4.60%) ▼|XOM136.85+0.13 (+0.10%) ▲|AAPL295.18+5.82 (+2.01%) ▲|ABBV249.56-2.08 (-0.83%) ▼|ABT92.85+2.11 (+2.33%) ▲|ACN131.13+6.69 (+5.38%) ▲|ADBE212.61+7.59 (+3.70%) ▲|AMAT663.31-59.69 (-8.26%) ▼|AMD551.15-29.77 (-5.12%) ▼|AMGN360.80-1.32 (-0.36%) ▼|AMT165.55+1.98 (+1.21%) ▲|AMZN241.81+3.47 (+1.46%) ▲|AVGO370.59-7.16 (-1.90%) ▼|AXP348.72+10.47 (+3.10%) ▲|BA217.87+1.40 (+0.65%) ▲|BAC58.23+1.25 (+2.19%) ▲|BKNG184.71+6.47 (+3.63%) ▲|BLK978.17+16.61 (+1.73%) ▲|BMY56.66-0.97 (-1.67%) ▼|BNY146.74+2.13 (+1.47%) ▲|BRK-B503.15+2.76 (+0.55%) ▲|C140.73+0.77 (+0.55%) ▲|CAT1,019.34-45.56 (-4.28%) ▼|CL92.49+0.81 (+0.88%) ▲|CMCSA24.16-0.39 (-1.59%) ▼|COF204.94+4.32 (+2.15%) ▲|COP103.74-0.22 (-0.21%) ▼|COST926.70-8.77 (-0.94%) ▼|CRM164.94+8.28 (+5.28%) ▲|CSCO116.33-1.13 (-0.96%) ▼|CVS104.11+0.66 (+0.63%) ▲|CVX166.32+0.56 (+0.34%) ▲|DE631.49-2.84 (-0.45%) ▼|DHR194.76+4.28 (+2.24%) ▲|DIS97.04+0.79 (+0.82%) ▲|DUK126.18-0.40 (-0.32%) ▼|EMR142.47-0.68 (-0.48%) ▼|FDX315.03+1.90 (+0.61%) ▲|GD364.11+9.87 (+2.79%) ▲|GE375.80+2.07 (+0.55%) ▲|GEV1,153.80-21.06 (-1.79%) ▼|GILD126.20-0.15 (-0.11%) ▼|GM76.53-0.56 (-0.72%) ▼|GOOG356.33+3.00 (+0.85%) ▲|GOOGL359.45+2.08 (+0.58%) ▲|GS1,024.23+12.86 (+1.27%) ▲|HD356.34+3.66 (+1.04%) ▲|HON224.19+0.29 (+0.13%) ▲|IBM293.10+11.89 (+4.23%) ▲|INTC129.30-10.33 (-7.40%) ▼|INTU272.00+11.00 (+4.21%) ▲|ISRG404.99+7.31 (+1.84%) ▲|JNJ252.34-1.63 (-0.64%) ▼|JPM334.34+7.01 (+2.14%) ▲|KO81.76+0.49 (+0.60%) ▲|LIN536.04+17.10 (+3.30%) ▲|LLY1,191.20-8.24 (-0.69%) ▼|LMT521.48+12.02 (+2.36%) ▲|LOW225.28+4.79 (+2.17%) ▲|LRCX396.34-36.99 (-8.54%) ▼|MA528.55+14.95 (+2.91%) ▲|MCD270.44+0.13 (+0.05%) ▲|MDLZ59.17+1.33 (+2.29%) ▲|MDT79.40+1.17 (+1.50%) ▲|META618.43+55.14 (+9.79%) ▲|MMM161.68-0.23 (-0.14%) ▼|MO71.96+0.01 (+0.01%) ▲|MRK126.59-1.91 (-1.49%) ▼|MS211.51+2.47 (+1.18%) ▲|MSFT384.67+11.65 (+3.12%) ▲|MU1,053.73-100.57 (-8.71%) ▼|NEE86.95-0.82 (-0.93%) ▼|NFLX73.39+1.99 (+2.78%) ▲|NKE43.06+2.01 (+4.90%) ▲|NOW105.65+6.37 (+6.42%) ▲|NVDA196.89-3.20 (-1.60%) ▼|ORCL145.11-1.44 (-0.98%) ▼|PEP140.05+4.65 (+3.43%) ▲|PFE23.94-0.15 (-0.60%) ▼|PG146.37-0.27 (-0.18%) ▼|PLTR127.19+10.52 (+9.02%) ▲|PM178.43-2.48 (-1.37%) ▼|QCOM185.52+0.73 (+0.39%) ▲|RTX191.39+1.66 (+0.87%) ▲|SBUX101.57-0.63 (-0.61%) ▼|SCHW94.40+2.13 (+2.31%) ▲|SO95.79+0.08 (+0.08%) ▲|SPG221.82-1.84 (-0.82%) ▼|T20.64-0.06 (-0.29%) ▼|TMO520.60+19.24 (+3.84%) ▲|TMUS172.53+4.80 (+2.86%) ▲|TSLA429.34+8.74 (+2.08%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.35+1.19 (+1.65%) ▲|UNH421.65+6.02 (+1.45%) ▲|UNP276.15+4.15 (+1.53%) ▲|UPS109.83+2.33 (+2.17%) ▲|USB61.98+1.58 (+2.62%) ▲|V352.39+9.30 (+2.71%) ▲|VZ42.08-0.27 (-0.63%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.05-5.21 (-4.60%) ▼|XOM136.85+0.13 (+0.10%) ▲|
29 C
New York
Wednesday, July 1, 2026

Tag: medical

Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera® (zanidatamab) for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

– Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b trial – DUBLIN, July 1, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...

Greenstein & Pittari, LLP Warns New Yorkers About the Hidden Dangers of Toxic Mold Exposure

NEW YORK, July 1, 2025 /PRNewswire/ -- Greenstein & Pittari, LLP, a premier New York City personal injury law firm, is raising urgent public...

Dr. Michael Lebow Launches Nationwide Scholarship Initiative to Support Aspiring Healthcare Professionals in the United States

ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) -- The Dr. Michael Lebow Scholarship for Future Doctors is now officially open for applications, inviting undergraduate students across the United States to compete for a one-time academic award designed to support and encourage future leaders in the healthcare field. This prestigious scholarship, created by esteemed vascular surgeon Dr. Michael Lebow, is committed to recognizing students who have demonstrated academic excellence, a passion for medicine, and a clear vision for positively impacting the healthcare industry.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

Energy Fuels’ Pinyon Plain Uranium Mine Continues to Outperform

The Company mined 638,700 pounds of uranium from its Pinyon Plain mine in Arizona during the 2nd quarter of 2025, cementing its place as...

Energy Fuels’ Pinyon Plain Uranium Mine Continues to Outperform

The Company mined 638,700 pounds of uranium from its Pinyon Plain mine in Arizona during the 2nd quarter of 2025, cementing its place as...

Indonesia’s Top Employers Forge the Future of Work: HR Asia Honors 80 Companies in Talent Innovation

JAKARTA, Indonesia, July 01, 2025 (GLOBE NEWSWIRE) -- HR Asia Best Companies to Work for in Asia, owned by Business Media International, proudly honours 80 organizations that exemplify excellence in human capital strategy and workplace culture. This year’s ceremony arrives as Indonesian companies navigate critical challenges in talent retention, multigenerational workforce integration, and shifting employee expectations.

Pioneering Global Presence, Empowering the World – Zuowei Technology Shining at WHX Miami Medical Expo

SHENZHEN, China, July 1, 2025 /PRNewswire/ -- From June 11 to 13, the 2025 WHX Miami Medical Expo (formerly known as FIME), the annual grand event...

Hemispherian Receives U.S. FDA Orphan Drug Designation for GLIX1 for the Treatment of Malignant Glioma

OSLO, Norway, July 1, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the U.S....

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss

Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently exist
Rincell-1 addresses a multi $Bn global market opportunity  where no disease modifying treatments currently exist

HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology...

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

EINDHOVEN, the Netherlands, July 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announced the submission of two major regulatory applications for its ARC-EX System. The Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) seeking clearance to expand its indication for home use. In parallel, ONWARD has filed an application with the notified body for CE Mark certification in accordance with the European Union Medical Device Regulation (MDR) to enable commercialization of the ARC-EX System in the EU. Completed in June, these submissions represent significant milestones as the Company advances its mission to bring breakthrough therapies to people with SCI around the world.

From Gaza to Africa: Equalall widens its Urgent Global Fundraising Drive to Support Crisis-Affected Communities in Africa

Global non-profit Equalall has so far been involved in fundraising for and mobilizing life-saving aid for victims of war, displacement, and natural disasters in Gaza, Syria, Sudan
Global non-profit Equalall has so far been involved in fundraising for and mobilizing life-saving aid for victims of war, displacement, and natural disasters in Gaza, Syria, Sudan

Trip.com Group Pioneers a Greener, More Inclusive Global Travel Ecosystem in 2024 Sustainability Report

Group launches new full-scale carbon emissions data feature across transport modesCountry Retreats Programme expands to more global destinations, driving rural developmentChampioning greater inclusion in...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedical